These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16931897)

  • 1. Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents.
    Remane Y; Leopold CS
    Skin Pharmacol Physiol; 2006; 19(6):303-10. PubMed ID: 16931897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous penetration of methyl nicotinate from ointments using the laser Doppler technique: bioequivalence and enhancer effects.
    Remane Y; Leopold CS; Maibach HI
    J Pharmacokinet Pharmacodyn; 2006 Dec; 33(6):719-35. PubMed ID: 17006769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ointment formulation on skin erythema induced by nicotinate esters.
    Realdon N; Ragazzi E; Dal Zotto M; Ragazzi E
    Pharmazie; 1995 Sep; 50(9):603-6. PubMed ID: 7480096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of bioavailability by lowering of fat content in topical formulations.
    Wirén K; Frithiof H; Sjöqvist C; Lodén M
    Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of release and simulated absorption of methyl nicotinate from different ointment formulations: in vitro-in vivo correlations.
    Realdon N; Ragazzi E; Dal Zotto M; Ragazzi E
    Pharmazie; 1996 Feb; 51(2):113-6. PubMed ID: 8720806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of the experimental methodology described in the FDA guidance for corticosteroid bioequivalence testing to pharmacodynamic effects caused by nicotinates.
    Remane Y; Leopold CS
    J Cosmet Dermatol; 2006 Dec; 5(4):289-93. PubMed ID: 17716246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing effects of lipophilic vehicles on skin penetration of methyl nicotinate in vivo.
    Leopold CS; Lippold BC
    J Pharm Sci; 1995 Feb; 84(2):195-8. PubMed ID: 7738800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cream and ointment bases on the steady state penetration of permeants through intact skin: the reciprocal of the onset time of a pharmacodynamic effect as parameter of response.
    Leopold CS
    Int J Cosmet Sci; 2000 Apr; 22(2):133-45. PubMed ID: 18503468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles.
    Puglia C; Esposito E; Menegatti E; Nastruzzi C; Rizza L; Cortesi R; Bonina F
    J Pharm Pharmacol; 2005 Sep; 57(9):1169-76. PubMed ID: 16105237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a minimal erythema concentration of methyl nicotinate for optimum evaluation of anti-inflammatories.
    Jumbelic LC; Liebel FT; Southall MD
    Skin Pharmacol Physiol; 2006; 19(3):147-52. PubMed ID: 16612142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
    Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
    Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessments of the percutaneous absorption of methyl nicotinate in humans.
    Guy RH; Wester RC; Tur E; Maibach HI
    J Pharm Sci; 1983 Sep; 72(9):1077-9. PubMed ID: 6631699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of blood flow after topical application of benzyl nicotinate on different anatomic sites.
    Jacobi U; Kaiser M; Sterry W; Lademann J
    Arch Dermatol Res; 2006 Nov; 298(6):291-300. PubMed ID: 16967307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between percutaneous penetration of methyl nicotinate and sensitive skin, using laser Doppler imaging.
    Issachar N; Gall Y; Borrel MT; Poelman MC
    Contact Dermatitis; 1998 Oct; 39(4):182-6. PubMed ID: 9817223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic measurements of methyl nicotinate percutaneous absorption: the effect of aging on microcirculation.
    Roskos KV; Bircher AJ; Maibach HI; Guy RH
    Br J Dermatol; 1990 Feb; 122(2):165-71. PubMed ID: 2317445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of various vehicles on the penetration of flufenamic acid into human skin.
    Wagner H; Kostka KH; Adelhardt W; Schaefer UF
    Eur J Pharm Biopharm; 2004 Jul; 58(1):121-9. PubMed ID: 15207545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of processing conditions in the manufacture of O/W creams: II. Effect on drug availability.
    Realdon N; Ragazzi E; Morpurgo M; Ragazzi E
    Farmaco; 2002 May; 57(5):349-53. PubMed ID: 12058808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the in vivo bioavailability of iontophoretically delivered diclofenac using a methyl nicotinate skin inflammation assay.
    Lambrecht R; Clarys P; Clijsen R; Barel AO
    Skin Res Technol; 2006 Aug; 12(3):211-6. PubMed ID: 16827697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ultrasound on the percutaneous absorption of nicotinate esters.
    Benson HA; McElnay JC; Harland R; Hadgraft J
    Pharm Res; 1991 Feb; 8(2):204-9. PubMed ID: 2023868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of skin colour on the detection of cutaneous erythema and tanning phenomena using reflectance spectrophotometry.
    Latreille J; Gardinier S; Ambroisine L; Mauger E; Tenenhaus M; Guéhenneux S; Morizot F; Tschachler E; Guinot C
    Skin Res Technol; 2007 Aug; 13(3):236-41. PubMed ID: 17610644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.